-
Mashup Score: 13Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma | GSK - 11 day(s) ago
Full data to be presented at 2024 American Society of Hematology Annual Meeting in December.
Source: www.gsk.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Home | GSK - 26 day(s) ago
At GSK, we unite science, technology and talent to get ahead of disease together
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
RT @GSK: News for #Investors and #Media Explore our full year 2023 figures at a glance. Dive into the data: https://t.co/iq6ccrYH5Q. $GSK…
-
-
Mashup Score: 2Respiratory/ immunology | GSK - 1 month(s) ago
We are advancing the frontiers of respiratory science and leveraging our understanding of the immune system to transform patient outcomes.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We’re excited to be at @ASNKidney week. As long-standing leaders in the #lupus community, we know how critical disease management is to try to help reduce organ damage progression for patients. Learn more: https://t.co/eFwdkoCHQ5 #KidneyWk https://t.co/DPHXzRIvl3
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
Thanks for joining us at #IDWeek2024, where we’ve been sharing scientific advances from our industry-leading, prevention-focused portfolio of infectious disease vaccines and medicines. 🔗 Find out more: https://t.co/qOYDNKvjbo 👈 https://t.co/Lve90N5awb
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We are excited to be at #IDWeek2024 to present research from across our broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious diseases. 🔗 Learn how are we developing new ways to prevent and treat infectious diseases: https://t.co/vjzT8e5O2i https://t.co/8ttHoo7dSH
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
Are you attending #IDWeek2024? So are we! Join us as we convene with global experts, sharing the latest advancements in the prevention and treatment of infectious diseases. 🔗 Learn more: https://t.co/U2gzuostqu
-
-
Mashup Score: 1‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it | GSK - 2 month(s) ago
As bacteria evolve to outsmart antibiotics, proactive action and preventative interventions will play a critical role
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
By 2050, 1 death every 3 minutes could be due to antimicrobial resistance. That's why this week, at #UNGA79, we must come together to prevent and get ahead of AMR. Read on for more about the human cost of AMR – and how to stop it: https://t.co/vKz8nmqOXl
-
-
Mashup Score: 3History and heritage | GSK - 3 month(s) ago
It began when Plough Court Pharmacy was established in 1715. Discover GSK’s journey to the company we are today
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
100 years ago today, we launched Ostelin, the world’s first Vitamin D supplement. Step back to 1924 with us to explore the history of our first pharmaceutical product. Read more about our heritage of innovation 👉 https://t.co/YWyHacClVo
-
-
Mashup Score: 2‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage | GSK - 6 month(s) ago
In just one asthma or COPD attack, irreversible changes to the tissue of the lungs can occur, effectively leaving them scarred
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We are sharing our industry-leading respiratory portfolio by talking to leaders, advocates and partners about respiratory and prevention to change the course of disease #ATS2024 https://t.co/F4WIjcEBIG https://t.co/Ro4pJdZryQ
-
-
Mashup Score: 1‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage | GSK - 6 month(s) ago
In just one asthma or COPD attack, irreversible changes to the tissue of the lungs can occur, effectively leaving them scarred
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We are excited to be at #ATS2024, where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions. Follow us for more. https://t.co/9xc5hk8N5L https://t.co/6dlvUFBzvA
-
Belantamab/Vd showed OS compared to DVd! Another BCMA directed therapy showing OS over Dara based therapy! More to come next #ASH24 #mmsm #myeloma #MedTwitter @OncoAlert https://t.co/1WXfNrFA7Q